Escherichia coli F-18, a normal human fecal isolate, is an excellent colonizer of the streptomycin-treated mouse large intestine. E. coli F-18 Col-, a derivative of E. coli F-18 which no longer makes the E. coli F-18 colicin, colonizes the large intestine as well as E. coli F-18 when fed to mice alone but is eliminated when fed together with E. coli F-18. Random sequences of E. coli F-18 DNA were cloned into pRLB2, a parB-stabilized derivative of pHC79. The entire gene library was transformed into E. coli F-18 Col-and fed to streptomycintreated mice. The mouse large intestine selected a predominant clone which contained a recombinant plasmid (pRLB7) that enhanced E. coli F-18 Col-colonizing ability 100-fold but did not stimulate colicin synthesis. Moreover, pRLB7 simultaneously improved the survival of E. coli F-18 Colin stationary phase in vitro, utilizing nutrients derived from mouse cecal mucus, and stimulated synthesis of both type 1 fimbriae and three E. col F-18 Colouter membrane proteins (74, 71, and 69 kDa). The 6.5-kb E. coli F-18 DNA sequence in pRLB7 does not contain either the fim operon or pilG (hns), both known to be involved in type 1 fimbrial synthesis. The sequence encodes six proteins, all smaller than the three E. coi F-18 Colouter membrane proteins whose synthesis it stimulates. Collectively, the results suggest that the cloned E. coli F-18 DNA sequence contains one or more regulators of E. coli F-18 Coloperons expressed in the mouse large intestine in vivo and in isolated mouse cecal mucus in vitro. V (5). A spontaneous double mutant of E. coli HB101
When fed simultaneously to streptomycin-treated mice, Escherichia coli F-18, isolated from the feces of a healthy human, is a far better colonizer of the mouse large intestine than E. coli F-18 Col-, a strain derived from E. coli F-18 (5) which no longer makes the E. coli F-18 colicin, colicin V (25) . It is highly likely that both E. coli F-18 and E. coli F-18 Col-colonize the mouse large intestine by growing in intestinal mucus; i.e., both strains grow well when inoculated alone into cecal mucus in vitro, but neither grows in cecal luminal contents in vitro (31) . Moreover, although both strains grow well alone in cecal mucus, together E. coli F-18 grows well and E. coli F-18 Colgrows poorly (31) .
Recently, we reported that, when streptomycin-treated mice were simultaneously fed 108 CFU of E. coli F-18 Coland 103 CFU of E. coli F-18, E. coli F-18 became the predominant strain within 5 days (31) . This observation suggested the possibility of cloning random sequences of E. coli F-18 DNA vitro, and increased synthesis of both type 1 fimbriae and at least three outer membrane proteins.
MATERIALS AND METHODS Bacterial strains. E. coli F-18 was isolated from the feces of a healthy human in 1977 and is an excellent colonizer of the streptomycin-treated mouse large intestine (5, 26) . The E. coli F-18 strain used here is resistant to streptomycin (Strr) and rifampin (Rif) and produces colicin V (25) . Its serotype is rough:Kl:H5 (25) . E. coli F-18 Col-fimA was made (25) by bacteriophage P1 transduction into E. coli F-18 from E. coli ORN151, which contains the tetracycline resistance gene from TnlO inserted in the fimA (pilA) gene (25) , making it type 1 fimbria negative. E. coli F-18 Colwas isolated in 1979 in the following way (5) . A Strr, nalidixic acid-resistant (Nalr) mutant of E. coli F-18 was mated with E. coli RS2, which contains the Rl drdl9 plasmid (R1+), and an E. coli F-18 R1+ strain was isolated. The E. coli F-18 R1+ strain was cured of the Rl drd plasmid with acriflavine. One of the cured clones, E. coli F-18 Col-, lost the ability to make the E. coli F-18 colicin (5) . E. coli F-18 Col-is a poor mouse large intestine colonizer relative to E. coli F-18 (5, 26) . At the time of isolation, E. coli F-18 Col-appeared to be missing an 86-kb plasmid (5) . When recently reexamined, however, E. coli F-18 Colwas found to contain the 86-kb plasmid, but it still does not make colicin V and remains a poor colonizer (data not shown). The colV plasmid is known to be able to insert into the E. coli chromosome (12) , which presumably accounts for its disappearance and reappearance in E. coli F-18 Col-. E (23), was partially digested with EcoRI. Digestion products in the 5to 15-kb range were used for subsequent ligation to EcoRI-restricted pRLB2, a pHC79 derivative described previously (4) . E. coli F-18 Colwas found to be a poor recipient for the relaxedcircular ligation products generated during plasmid bank construction. For this reason, ligation products were initially transformed into E. coli HB101. These colonies (10,000 CFU) were then mixed and added to 1 liter of L-broth containing ampicillin (100 ,ug/ml) grown to an optical density at 600 nm of 0.4, and plasmid DNA was amplified following addition of chloramphenicol (200 ,g/ml). Supercoiled plasmid DNA was then isolated by cesium chloride-ethidium bromide density centrifugation (22) . The resulting purified supercoiled plasmid DNA was assayed for variability by restriction analysis and then transformed into E. coli F-18 Colat high frequency (approximately 106 transformants per jig of DNA). These transformants, representing the shotguncloned E. coli F-18 gene library in E. coli F-18 Col-, were used for all subsequent in vivo selection experiments. Small-scale isolation of plasmid DNA was carried out by the method of Birnboim and Doly (2) . Agarose gel electrophoresis was carried out at a concentration of 0.8% agarose. All restriction endonuclease and T4 DNA ligase reactions were performed as described by the manufacturer (Bethesda Research Laboratories, Gaithersburg, Md.). Calf intestinal phosphatase and RNase I treatments were performed as specified by the manufacturer (Boehringer Mannheim Biochemicals, Indianapolis, Ind.). All restriction fragments were purified with GENECLEAN, using the instructions provided by the manufacturer (Bio 101, Inc., La Jolla, Calif.).
Plasmid pRLB7 deletion construction. The parB stabilized plasmid pRLB2, described previously (4), was used as the E. coli F-18 gene library recipient plasmid. Plasmid pRLB7 was selected by the mouse large intestine in vivo from the E. coli F-18 gene library in E. coli F-18 Col-. The restriction map of pRLB7 is presented in Fig. 1 . pRLB18 is a deletion which extends from the XhoI site to the SalI site of pRLB7 and was constructed by digesting pRLB7 with XhoI and SalI and religating the deleted plasmid by virtue of XhoI and Sall restriction site compatibility. All plasmids used in this study are listed in Table 1 .
Mouse colonization experiments. The method used to distinguish the relative colonizing abilities of E. coli strains in mice has been described in detail previously (5, 31) . Briefly, after 1 day of being fed streptomycin sulfate in their drinking water (5 g/liter), male CD-1 mice (5 to 8 weeks old) were starved for food (Charles River Valley Rat, Mouse, and Hamster Formula) and water for 18 to 24 h and fed 1010 CFU each of the L-broth-grown E. coli strains to be tested in 1 ml of sterile 20% (wt/vol) sucrose. The mice drank the bacterial suspension almost immediately and were then given food and streptomycin-containing drinking water. The next day and at 48-h intervals, fecal samples, no older than 24 h, were collected, homogenized, diluted, and plated on selective media as described below. In all colonization experiments, plates were incubated at 37°C for 18 to 24 h. Colonizing ability was assessed by the level at which a strain persisted in feces. Each experiment was performed at least twice, with essentially identical results.
To differentiate between E. coli F-18 Colstrains carrying recombinant plasmids and E. coli F-18 Col-fimA(pRLB2), fecal samples were plated on MacConkey agar containing 100 ,ug of streptomycin sulfate and 100 ,g of ampicillin per ml and on MacConkey agar containing 100 p,g of streptomycin sulfate, 100 p,g of ampicillin, and 10 ,ug of tetracycline hydrochoride per ml. The former medium grows both strains being tested, whereas the latter medium only grows the E. coli F-18 Col-fimA(pRLB2) strain. When necessary, i.e., when the numbers of CFU on the two media were difficult to distinguish as different, 100 colonies were typed by transferring samples of each by toothpick from the plates without tetracycline to the plates containing tetracycline.
Growth in cecal mucus dialysates. Cecal mucus dialysates were prepared from CD-1 mouse crude cecal mucus as and tetracycline hydrochloride (10 jig/ml), and after incubation colonies were scored for either resistance or sensitivity to tetracycline. Plate test for colicin production. The indicator strain used to detect colicin production was E. coli ORN152 (25) . Approximately 106 CFU from an aerobically grown L-broth overnight culture (37°C) was spread on the surface of an L-agar plate. The strain to be examined for colicin production was transferred by toothpick from a fresh streak to the plate containing the indicator strain. After overnight incubation at 37°C, colonies of the test strain were examined for zones of inhibition.
Radioactive labeling of E. coli F-18 Colstrains during growth in mouse cecal mucus. E. coli F-18 Col-strains and their plasmid-containing derivatives were grown in L-broth as described previously (25) and diluted 104-fold in HEPES (N-2-hydroxyethylpiperazine -N' -2-ethanesulfonic acid)-Hanks buffer (pH 7.4) into 2 ml of crude cecal mucus (4 mg of protein per ml) containing 10 ,uCi of Tran35S-label (1, 100 Ci/mmol; ICN Biomedicals, Inc., Costa Mesa, Calif.) per ml. Cultures were incubated standing for 16 h at 37°C, washed twice in HEPES-Hanks buffer (pH 7.4), and resuspended in the same buffer at a concentration of about 109 CFU/ml. The specific activity of the cultures was routinely between 2 x i-3 and 5 x 10-' cpm/CFU. Adhesion assay. The adhesion assay has been described in detail previously (25) . Briefly, 35S-labeled cells (0.2 ml) in HEPES-Hanks buffer (pH 7.4) or 35S-labeled cells (0.2 ml) in HEPES-Hanks buffer (pH 7.4) containing a-methyl-D-mannoside (100 mM) were added to multiwell polystyrene plates containing an immobilized mannose-bovine serum albumin (BSA) glycoconjugate (Carbohydrates International, Arlov, Sweden). The plates were incubated for 1 h at 37°C, and the wells were then washed twice with HEPES-Hanks buffer (pH 7.4) to remove unbound bacteria. Adherent bacteria were released by adding 0.5 ml of 5% sodium dodecyl sulfate (SDS) to each well and then incubating the plates for 3 h at 37°C. The SDS was removed from each well, and the level of radioactivity was determined by scintillation counting.
Isolation of outer membranes and periplasm. The periplasm of 35S-labeled cells grown in cecal mucus was released from spheroplasts (21) . Spheroplasts were centrifuged at 15,000 x g for 10 min at 4°C, resuspended in 30 mM Tris buffer (pH 7.3) containing 3 mM EDTA, and lysed by sonication. Surviving spheroplasts were removed by centrifugation at 15,000 x g for 5 min at 4°C, and the supernatant was centrifuged at 40,000 x g for 90 min at 4°C to collect whole cell membranes. Outer membranes were then prepared from whole membranes by differential centrifugation, using the detergent sodium dodecyl sarcosinate as described by Filip et al. (9) .
Purification and quantitation of type 1 fimbriae. E. coli F-18 Col-strains were grown in 100 ml of Minimal Broth Davis (Difco) containing 1% (wt/vol) D-glucose as described previously (25) . Fimbriae were purified from each strain as described by Eisenstein and Dodd with minor modifications (7) . Briefly, bacteria were collected by centrifugation and were then washed and resuspended in Tris-HCl buffer (pH 7.4). The fimbriae were sheared off by blending. Bacterial cells and membrane debris were removed by centrifugation, and the supernatant was subjected to ultracentrifugation (227,000 x g, 2 h, 4°C). Labeling of plasmid-encoded proteins by the 17 RNA polymerase/promoter system. E. coli K38 cells containing both plasmid pGP1-2 and the plasmid to be tested were grown in L-broth containing 40 jig of ampicillin and 40 pg of kanamycin sulfate per ml at 30°C. AtA590 = 0.5, 0.2 ml of cells was centrifuged and washed with 5 ml of M9 medium, recentrifuged, and resuspended in 1 ml of M9 medium supplemented with 20 ,ug of thiamine per ml and 0.01% of 18 amino acids (i.e., no cysteine or methionine). Cells were grown with shaking at 30°C for 60 min and then shifted to 42°C for 15 min to lift repression on T7 RNA polymerase synthesis (30) .
Rifampin was added to a final concentration of 200 ,ug/ml to block E. coli K38 RNA polymerase activity (30) , and the incubation was continued at 42°C for 10 min. The temperature was then shifted to 30°C for 20 min, and the cells were pulsed with 10 p,Ci of Tran35S-label per ml for 10 min at 30°C. Finally, the cells were centrifuged for 20 s in an Eppendorf 5415 centrifuge and subjected to SDS-PAGE and autoradiography, as described previously (32 buffer (1.5 M sodium chloride, 0.5 M sodium hydroxide) for 40 min, washed twice with water, and finally placed in neutralization buffer (3 M sodium citrate, pH 5.5) for 60 min. The filters were prehybridized in 0.25 M phosphate buffer (pH 7.2) containing 6% SDS, 1 mM EDTA, and 50 ,g of denatured salmon sperm DNA per ml at 65°C for 60 min. The filters were then hybridized with probe in the same solution as described above, in the absence of salmon sperm DNA, for 18 h at 65°C. The filters were then washed four times for 15 min each time at 65°C in 20 mM phosphate buffer (pH 7.2) containing 1% SDS and then washed once for 15 min at 65°C in 10 mM phosphate buffer (pH 7.2) containing 0.5% SDS. Autoradiography was performed as described previously (32).
RESULTS
In vivo selection of an E. coli F-18 DNA fragment that enhances E. coli F-18 Colcolonizing ability. Three streptomycin-treated mice were fed 1010 CFU of E. coli F-18 Colcells containing random E. coli F-18 DNA fragments cloned into pRLB2. On day 9 postfeeding, 16 colonies were selected from the feces of each mouse and characterized. Of the 48 colonies, 44 contained a recombinant plasmid which by restriction enzyme analysis appeared to contain the same insert (Fig. 1) . One plasmid, termed pRLB7, was used in further experiments.
pRLB7 was transformed into a fresh E. coli F-18 Colbackground, and one colony was selected and designated E. coli F-18 Col-(pRLB7). This strain (1010 CFU) was fed to eight streptomycin-treated mice along with 101U CFU of E. coli F-18 Col-fimA(pRLB2), which colonizes as well as E. coli F-18 Col-(pRLB2) (data not shown). E. coli F- 18 Col-(pRLB7) colonized at about 5 x 107 CFU/g of feces, whereas E. coli F-18 Col-fimA(pRLB2) colonized at a level of only 5 x 105 CFU/g of feces; i.e., pRLB7 contained a sequence that appeared to improve the colonizing ability of E. coli F-18 Col-100-fold ( Fig. 2A) .
Additional control experiments were performed to be sure that pRLB7 enhanced E. coli F-18 Colcolonizing ability. First, 1010 CFU of E. coli F-18 Colcontaining a random 4.5-kb E. coli F-18 DNA insert in pRLB2 and 101 CFU of E. coli F-18 Col-fimA(pRLB2) were simultaneously fed to three streptomycin-treated mice. Both strains colonized equally well at about 107 CFU/g of feces (data not shown).
Second, and of greater importance, a 4.5-kb XhoI to Sall deletion of pRLB7, designated pRLB18 ( Fig. 1) , was transformed into E. coli F-18 Col-. This strain, E. coli F-18 Col-(pRLB18), and E. coli F-18 Col-fimA (pRLB2) were simultaneously fed (1010 CFU of each) to nine streptomycintreated mice. Both strains colonized equally well at about 5 x 106 CFU/g of feces (Fig. 2B) . These control experiments supported the idea that pRLB7 contains a specific E. coli F-18 DNA sequence that enhances E. coli F-18 Colmouse large intestine colonizing ability.
In the colonization experiments described above, we used E. coli F-18 Col-fimA(pRLB2) because it has the tetracycline resistance gene from TnlO inserted into fimA and we could use the tetracycline resistance phenotype in cofeeding experiments to determine whether E. coli F-18 Col-(pRLB7) was the better colonizer. However, it might be argued that E. coli F-18 Col-fimA(pRLB2) was a bad choice since the E. coli F-18 DNA sequence in pRLB7 was subsequently shown to result in increased synthesis of type 1 fimbriae in E. coli F-18 Col-(see below). Therefore, E. coli F-18 Col-fimA(pRLB7) was constructed and fed to six mice simulta- neously with E. coli F-18 Col-(pRLB2). The two strains were differentiated in mouse feces by transferring by toothpick 100 colonies from each mouse at each time of sampling to MacConkey plates containing tetracycline (10 ,ug/ml). Under these conditions, E. coli F-18 Col-fimA(pRLB7) colonized at a level of about 5 x 107 CFU/g of feces, whereas E. coli F-18 Col-(pRLB2) colonized at some level below 5 x 105 CFU/g of feces, i.e., at least 2 orders of magnitude lower (data not shown). Therefore, pRLB7 contains an E. coli F-18 DNA sequence which increases the colonizing ability of both E. coli F-18 Coland E. coli F-18 Col-fimA.
Colicin test. E. coli F-18 Col-, E. coli F-18 Col-(pRLB2), E. coli F-18 Col-(pRLB7), E. coli F-18 Col-(pRLB18), and E. coli F-18 were tested for colicin production (see Materials and Methods). Only E. coli F-18 produced the colicin. Moreover, E. coli F-18 Col-(pRLB7) and E. coli F-18 were fed separately to three mice and were allowed to colonize for 30 days, and then colonies from each mouse were tested for colicin production. E. coli F-18 Col-(pRLB7) was colicin negative, whereas the zones of inhibition around the E. coli F-18 colonies were far larger than those produced by E. coli F-18 colonies isolated from frozen stocks. These results suggest that pRLB7 does not enhance E. coli F-18 Colcolonizing ability by inducing the synthesis of the E. coli F-18 colicin, colicin V.
Restriction mapping of pRLB7. The E. coli F-18 DNA in pRLB7 was mapped to an approximately 6.5-kb PstI-EcoRI fragment (Fig. 1) . The actual border on the PstI side of the E. coli F-18 insertion could not be determined because residual (Fig. 1 ). Sequence analysis of this region will be necessary to locate the exact position defining the plasmidinsert border.
Effect of pRLB7 on E. coli F-18 Colgrowth and survival in vitro. E. coli F-18 grows as well in a mouse cecal mucus dialysate as in crude mouse cecal mucus (10) . E. coli F-18 Col-(pRLB7) and E. coli F-18 Col-fimA(pRLB2) were inoculated simultaneously into the cecal mucus dialysate, each at a level of approximately 104 CFU/ml. The strains grew equally well during the exponential phase of growth from 10 to about 108 CFU/ml, with doubling times of about 36 min. However, significant differences were noted during stationary phase. That is, in a typical experiment illustrated in Fig. 3 , the ratio of E. coli F-18 Col-(pRLB7) to E. coli F-18 Col-fimA(pRLB2) changed from 1.0 during the exponential phase of growth to 3.6 during stationary phase; i.e., pRLB7 appeared to give E. coli F-18 Colsurvival advantage over E. coli F-18 Col-fimA(pRLB2) in stationary phase. In support of this view, pRLB7 also afforded E. coli F-18 Col-fimA the same survival advantage in stationary phase when grown together with E. coli F-18 Col-(pRLB2) in cecal mucus dialysates (data not shown). Moreover, the survival advantage in stationary phase was abolished when E. coli F-18 Col-(pRLB18), the XhoI-Sall deletion derivative of pRLB7, was grown together with E. coli F-18 Col-fimA(pRLB2) in cecal mucus dialysates (data not shown).
pRLB7-directed stimulation of synthesis of type 1 fimbriae. E. coli F-18 makes type 1 fimbriae in L-broth in vitro (19) , and E. coli F-18 type 1 synthesis appears to be stimulated during growth in mouse cecal mucus in vivo (19) . pRLB7 was therefore tested for its ability to stimulate type 1 fimbrial synthesis in E. coli F-18 Col-. E. coli F-18 Col-(pRLB7), E. coli F-18 Col-(pRLB18), E. coli F-18 Col-(pRLB2), E. coli F-18 Col-, and E. coli F-18fimA were grown in cecal mucus in vitro and tested for abilities to bind specifically to a mannose-BSA glycoconjugate (see Materials and Methods). pRLB7 stimulated adhesion to mannose-BSA greater than 10-fold relative to pRLB2 ( Table 2 ). The XhoI-SalI deletion, pRLB18, which does not enhance E. coli F-18 Col-colonizing ability (Fig. 1B) , did not stimulate adhesion to mannose-BSA ( Table 2) .
When the E. coli F-18 Colstrains containing the recombinant plasmids were grown in Minimal Broth Davis containing 1% (wt/vol) D-glucose and tested for their abilities to bind to mannose-BSA, results similar to those depicted in Table 2 were obtained (not shown). Therefore, type 1 fimbriae were purified from these cultures and quantified. E. coli F-18 Col-(pRLB7) produced three to four times as much type 1 fimbrial protein as E. coli F-18 Col-, E. coli F-18 Col-(pRLB2), and E. coli F-18 Col-(pRLB18) ( Table 3) , further supporting the idea that the E. coli F-18 DNA in pRLB7 encodes a gene(s) which stimulates the synthesis of type 1 fimbriae. pRLB7 does not contain the fin region or pilG (hns). The fim (pi) operon contains both regulatory and structural genes for type 1 fimbrial synthesis (17) . pilG (hns), which maps outside the fim operon, is thought to regulate the frequency of switching of the fimA invertible promoter (29) . As shown by Southern blot analysis, neither fim nor pilG sequences are contained in pRLB7 (Fig. 4) F-18 and E. coli F-18 Colwere restricted with PstI and SalI and probed with the 32P-labeled PstI-SalI fragment of pRLB7. Both E. coli F-18 and E. coli F-18 Colcontain the same-size PstI-SalI fragment (Fig. 5 ). Therefore, although E. coli F-18 Colmay be defective in the PstI-SalI region, it contains the region.
pRLB7-directed synthesis of outer membrane proteins. pRLB7 appeared to increase the synthesis of type stationary phase in mouse cecal mucus in the presence of 35S-methionine and 15 S-cysteine (see Materials and Methods), and the outer membrane and periplasmic fractions of each strain were isolated, subjected to SDS-PAGE, and autoradiographed. No clear differences were found in the periplasmic fraction (not shown), but synthesis of three outer membrane proteins (74, 71, and 69 kDa) clearly appeared to be stimulated by pRLB7 ( Fig. 6 ). Moreover, pRLB18, the XhcI-SaiI deletion derivative, did not stimulate synthesis of the three E. ccli F-18 ColP outer membrane proteins ( Fig. 6 ). Therefore, the enhancement of synthesis of the three outer membrane proteins was due at least in part to the XhcI-Sall E. ccli F-18 sequence in pRLB7.
Proteins encoded by the PstI-SaLI fragment of pRLB7. The PstI-SaI frag-ment of pRLB7 was cloned into pGEM7Zf(+) in both directions immediately upstream of the bacteriophage T7 promoter, and the recombinant plasmids were transformed into E. ccli K38(pGP1-2) and tested for the proteins encoded by the fragment (see Materials and Methods). When transcription occurred in the PstI-Sall direction, three proteins were made (26, 22, and 20 kDa) ( Fig. 7) . When transcription occurred in the SalI-PstI direction, three different proteins were made (32.5, 28.5, and 27 kDa) (Fig. 6 ). The PstI-SalI fragment of pRLB7 contains approximately 5,400 bp, and the six proteins require only about 4,300 bp.
Since there may be as much as 1 kb of E. ccli F-18 DNA upstream of the PstI site and about 1 kb downstream of the SailI site in pRLB7, it is possible that the two largest proteins encoded by the E. ccli F-18 sequence in pRLB7 could be 65.5 kDa (i.e., 32.5 + 33.0 kDa) transcribed in the SalI-PstI direction and 59 kDa (i.e., 26 + 33.0 kDa) transcribed in the PstI-Sall direction. Even if this were the case, the three outer membrane proteins whose synthesis is stimulated by pRLB7 are all larger than the largest proteins that could be encoded by pRLB7, suggesting that the proteins encoded by pRLB7 are not the outer membrane proteins whose synthesis is stimulated by pRLB7 ( Fig. 7) . 
DISCUSSION
We have described the selection and partial characterization of an E. coli F-18 DNA sequence that enhances the mouse large intestine colonizing ability of E. coli F-18 Col-, a poor colonizing derivative of E. coli F-18 (Fig. 2) . This sequence simultaneously enhances the ability of E. coli F-18 Colto survive in stationary phase, utilizing nutrients derived from mouse cecal mucus (Fig. 3) , and stimulates synthesis of type 1 fimbriae (Table 2) . Also, the sequence appears to stimulate the synthesis of three outer membrane proteins in E. coli F-18 Col- (Fig. 6 ).
How might survival in stationary phase be a factor in E. coli F-18 Colmouse large intestine colonizing ability? As suggested by Freter (11) , it is possible that maintenance of a microorganism in the mouse large intestine depends on its ability to sequester small amounts of one or more nutrients which that microorganism utilizes exceptionally well. If so, as those nutrients become limiting, growth would slow considerably, i.e., a situation in the intestine perhaps akin to stationary phase. Of two nearly isogenic strains, the one that can utilize the preferred nutrients better under limiting conditions would become predominant. Alternatively, it is possible that expression of the E. coli F-18 DNA sequence in E. coli F-18 Colimproves its ability to survive in the presence of its own metabolic products, which again would enhance its large intestine colonizing ability. However, in this context, it should be noted that E. coli F-18 Col-(pRLB7) does not make colicin V, the colicin made by E. coli F-18 in vitro. It would therefore appear that pRLB7 does not enhance E. coli F-18 Colcolonizing ability or survival in stationary phase by inducing colicin V synthesis and then killing E. coli F-18 Col-(pRLB2).
The expression of type 1 fimbriae is subject to phase variation, i.e., oscillation between the fimbriate and afimbriate states, due to the stochastic inversion of a 314-bp DNA segment which contains the fimA promoter (1, 14) . The products of twofim genes,fimB andfimE (hyp), influence the frequency of inversion (14, 24, 27) . The gene product offimB appears to mediate inversion in both directions, with a moderate preference for the "on" orientation (24) , such that in the presence of a large excess of fimB product all cells express type 1 fimbriae (14) . The fimE product has recently been shown to promote inversion from "on" to "off" (24) . While we have shown here that the sequence we have isolated has no homology with the fim region ( Fig. 4) , it is still possible that it stimulates inversion to the "on" orientation by either increasing the rate of synthesis of the fimB protein or decreasing the rate of synthesis of the fimE protein.
Three other genes are known to play a role in the frequency of inversion. One of these genes is pilG (hns) (29) .
The sequence we describe here is notpilG (Fig. 4 ), but it is still possible that it regulatespilG expression. The other two genes are himA and himD (hip), which encode the a and P subunits of integration host factor, respectively, which is required for efficient recombination of the fim invertible element (6, 8) . While we have not unequivocally ruled out that our sequence contains a himA or himD gene, it is clear from transmission electron microscopy studies that all modified Davis minimal medium (32)-grown E. coli F-18 Colcells which contain an extra fimB gene in trans express type 1 fimbriae compared with expression by only 0.5% of cells in its absence (unpublished observations). Therefore, it is highly likely that E. coli F-18 Colcontains functional himA and himD (hip) genes and that the sequence we have isolated contains a previously unidentified regulator of type 1 fimbrial synthesis. The sequence we describe here appears to regulate the synthesis of not only type 1 fimbriae, but also three outer membrane proteins (Fig. 6 ). The evidence for this is twofold. First, the three outer membrane proteins that are affected by the sequence appear to be made in its absence in E. coli F-18 Col-, but at reduced levels (Fig. 6) . Second, the six proteins encoded by the sequence are all smaller than the three outer membrane proteins and are therefore likely to be playing a regulatory rather than a structural role. The three outer membrane proteins do not appear to be fim-encoded surface proteins which are either too small, i.e., FimA, FimF, FimG, and FimH (18), or too large, i.e., FimD (15) . Whether one or more of the three outer membrane proteins play an important role in the colonization process is presently under investigation.
At the present time, we do not know whether the genes in the sequence that regulate synthesis of type 1 fimbriae are the same genes that enhance E. coli F-18 Collarge intestine colonizing ability. It is possible, for example, that colonizing ability is enhanced by expression of the genes in the sequence that are transcribed in one direction and that type 1 fimbrial synthesis is regulated by the genes in the sequence that are transcribed in the opposite direction ( Fig. 7) . Alternatively, it is possible that the sequence we have isolated contains a gene or genes that coordinately regulate both type 1 fimbrial synthesis and enhanced colonizing ability.
In summary, we have used the streptomycin-treated mouse large intestine to select an E. coli F-18 DNA sequence which enhances the colonizing ability of E. coli F-18 Col-. The enhancement in colonizing ability is accompanied by an increase in the ability of E. coli F-18 Colto survive stationary phase in vitro, utilizing cecal mucus nutrients. Simultaneously, the sequence stimulates the synthesis of both type 1 fimbriae and three E. coli F-18 Colouter membrane proteins.
VOL. 61, 1993 on August 20, 2018 by guest http://iai.asm.org/
